Effect of vitamin K preparations on hypoprothrombinaemia induced by dicoumarol and tromexan.
D000933:Antifibrinolytic Agents; D003374:Coumarins / Q000633:toxicity*; D001728:Dicumarol; D005017:Ethyl Biscoumacetate; D007020:Hypoprothrombinemias; D009285:Naphthoquinones; D011516:Prothrombin; D014812:Vitamin K / Q000627:therapeutic use*
D000933:Antifibrinolytic Agents; D003374:Coumarins; D009285:Naphthoquinones; D005017:Ethyl Biscoumacetate; D014812:Vitamin K; D001728:Dicumarol; D011516:Prothrombin; C030123:coumarin
COUMARIN/toxicity; PROTHROMBIN; VITAMIN K/therapeutic use